Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)
- Status
- COMPLETED
- Phase
- PHASE3
Study Assessed the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects.
- Status
- COMPLETED
- Phase
- PHASE2
PDR001 + Panobinostat for Melanoma and NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE1
A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients
- Status
- COMPLETED
- Phase
- PHASE4
Pediatric Long-Term Follow-up and Rollover Study
- Status
- RECRUITING
- Phase
- PHASE4
This Study Will Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC.
- Status
- TERMINATED
- Phase
- PHASE2
A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.
- Status
- COMPLETED
- Phase
- PHASE1
Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- Status
- RECRUITING
- Phase
- PHASE3
Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients
- Status
- TERMINATED
- Phase
- PHASE2
A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS).
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients
- Status
- TERMINATED
- Phase
- PHASE2
HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Safety of Brolucizumab 6 mg in Prefilled Syringe in Patients With Neovascular Age Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE3
Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2